Lunai Bioworks - 11 Year Stock Price History | LNAI
Historical daily share price chart and data for Lunai Bioworks since 2015 adjusted for splits and dividends. The latest closing stock price for Lunai Bioworks as of September 18, 2026 is 2.33.
- The all-time high Lunai Bioworks stock closing price was 1004.00 on November 30, 2021.
- The Lunai Bioworks 52-week high stock price is 14.40, which is 518% above the current share price.
- The Lunai Bioworks 52-week low stock price is 1.21, which is 48.1% below the current share price.
- The average Lunai Bioworks stock price for the last 52 weeks is 5.06.
| Lunai Bioworks Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 3.4115 | 7.7760 | 8.4800 | 1.4720 | 2.3300 | -66.98% |
| 2025 | 29.5083 | 61.0400 | 95.2000 | 6.6720 | 7.0560 | -89.45% |
| 2024 | 133.8260 | 255.2000 | 390.0000 | 33.0400 | 66.8800 | -73.63% |
| 2023 | 148.1971 | 89.6000 | 414.4000 | 32.0000 | 253.6000 | 207.77% |
| 2022 | 324.7315 | 594.4000 | 720.0000 | 82.4000 | 82.4000 | -85.87% |
| 2021 | 461.1302 | 252.8000 | 1004.0000 | 235.2000 | 583.2000 | 147.12% |
| 2020 | 291.5953 | 416.8000 | 484.8000 | 166.4000 | 236.0000 | -41.24% |
| 2019 | 472.1032 | 558.4000 | 740.0000 | 278.4000 | 401.6000 | -28.29% |
| 2018 | 405.4716 | 39.5000 | 678.4000 | 39.5000 | 560.0000 | 1078.95% |
| 2017 | 77.7104 | 16.0000 | 312.0000 | 7.0000 | 47.5000 | 216.67% |
| 2016 | 107.3441 | 312.0000 | 312.0000 | 7.5000 | 15.0000 | -95.19% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.000B |
| Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.703B | 42.61 |
| Tempus AI (TEM) | United States | $14.500B | 0.00 |
| 10x Genomics (TXG) | United States | $10.029B | 0.00 |
| Hinge Health (HNGE) | United States | $7.643B | 73.43 |
| Hims & Hers Health (HIMS) | United States | $6.507B | 0.00 |
| Doximity (DOCS) | United States | $4.736B | 29.20 |
| Heartflow (HTFL) | United States | $4.310B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.684B | 242.93 |
| Privia Health (PRVA) | United States | $2.566B | 95.67 |
| Clover Health Investments (CLOV) | United States | $2.411B | 0.00 |
| Schrodinger (SDGR) | United States | $2.232B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.120B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.04 |
| Omnicell (OMCL) | United States | $1.484B | 21.18 |
| Azenta (AZTA) | United States | $1.473B | 80.07 |
| Enovis (ENOV) | United States | $1.027B | 5.31 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.716B | 0.00 |
| Phreesia (PHR) | United States | $0.638B | 34.27 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Veradigm (MDRX) | United States | $0.587B | 0.00 |
| Claritev (CTEV) | United States | $0.538B | 0.00 |
| Carlsmed (CARL) | United States | $0.420B | 0.00 |
| Evolent Health (EVH) | United States | $0.415B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.394B | 0.00 |
| CapsoVision (CV) | United States | $0.317B | 0.00 |
| Standard BioTools (LAB) | United States | $0.287B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.135B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 6.94 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Outset Medical (OM) | United States | $0.058B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.047B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.027B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| HeartSciences (HSCS) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |